AIM To investigate the quality of life (QOL) and its influencing factors in patients with hypertrophic cardiomyopathy (HCM), and provide evidence for improving the QOL of HCM patients.
METHODS A total of 150 HCM patients were consecutively enrolled as subjects, and 150 healthy volunteers matched with age and sex were selected as control group. The QOL was measured with 36-item short-form Health Survey (SF-36), while clinical data and echocardiographic indicators were collected at the same time, and the influencing factors were further analyzed.
RESULTS The score of every domain and component summary in SF-36 for HCM patients was lower than control group (P<0.05). Further analysis showed that age ≥65 years (β=−0.153, P<0.05), female gender (β=−0.130, P<0.05), New York Heart Association (NYHA) functional class Ⅲ~Ⅳ (β=−0.213, P<0.01), left ventricular outflow tract obstruction (LVOTO) (β=−0.418, P<0.01), comorbidity (β=−0.174, P<0.01), depression (β=−0.389, P<0.01) and anxiety (β=−0.176, P<0.05) were independent risk factors in HCM patients.
CONCLUSION The QOL of HCM patients decrease in all dimensions, which is closely related to demographic factors, clinical features and emotional disorders. Therefore, in order to improve the QOL of HCM patients, health education and psychological intervention should be carried out according to the specific situation, in addition to relieving LVOTO and treating concomitant diseases.